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Abstract Leakage at the urethrovesical anastomosis in
the post-operative period can result in morbidity including
ileus. We examined the eVectiveness of using a Wbrin seal-
ant at the anastomosis to limit urine leakage thereby facili-
tating earlier Jackson–Pratt drain and Foley catheter
removal following robotic assisted laparoscopic prostatec-
tomy (RALRP). Forty consecutive patients underwent
RALRP by one surgeon at our institution. The Wrst 20
patients underwent standard operation and served as the
control group. The subsequent 20 patients underwent the
same operation with addition of Wbrin sealant following a
running absorbable sutured urethrovesical anastomosis. The
two groups were compared for age (60.5 vs. 58.2 years), pre-
operative PSA (5.23 vs. 4.71), Gleason score (6.3 vs. 6.5),
stage at resection, and prostate size at resection (51.7 vs.
47.7 g). Wilcoxon rank sum test determined no statistically
signiWcant diVerences in the groups. Patients in the Wbrin
sealant group had 1.3 versus 2.1 days with a Jackson–Pratt
drain, 9.75 versus 12.1 days with a catheter, and an average
of 38.6 versus 63.2 cc of drainage per shift. Catheters were
removed when a cystogram demonstrated no extravasation
of contrast. Two patients in the control group and no
patients in the Wbrin sealant group had large-volume leak-
age and ileus post-operatively. In patients undergoing
RALRP, application of Wbrin sealant at the urethrovesical
anastomosis appears to facilitate sealing, thereby allowing
earlier removal of the JP drain, by 0.8 days, and the Foley
catheter, by 2.35 days, than in controls. No patients in the
Wbrin sealant group suVered post-operative ileus. This
adjunct may be especially useful early in the learning pro-
cess to reduce morbidity.
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Introduction
First approved for use in 1988 [1] the applications of liquid
Wbrin sealant are expanding with current guidelines indicat-
ing improved safety and eYcacy of two-component Wbrin
sealant products such as Tisseel VH (Baxter, Westlake Vil-
lage, CA, USA) [2, 3]. Current applications in urology uti-
lize both the hemostatic and sealant properties. [4, 5] Fibrin
sealants have been used for urologic application including
partial nephrectomy (laparoscopic and open surgical proce-
dures), which takes advantage of the hemostatic properties
[5–7], and during hypospadias surgery, Wstula repair, and
urethroplasty, which employ the sealant properties. [6, 8, 9]
More recently, use of Wbrin sealant at the urethrovesical
anastomosis in radical retropubic prostatectomy has been
employed to facilitate earlier catheter removal [10] and
decreased urinary leakage [11]. No studies have been done
to date expanding this use into robotic surgery but, by infer-
ence, application of Wbrin sealant at the urethrovesical anas-
tomosis during RALRP may oVer advantages.
At our institution, patients undergoing robotic assisted
laparoscopic radical prostatectomy are routinely discharged
on post-operative day one with minimal morbidity. The
protocol for post-operative care is adjusted to account for
the minimally invasive nature of the procedure. Jackson–
Pratt drains are removed prior to discharge if volumes
remain less than 60 cc after ambulation. Foley catheters are
removed at one week if a cystogram shows no leak. In our
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VH, a two component Wbrinogen and activated thrombin
sealant, at the anastomosis of the urethra and bladder after
radical robotic prostatectomy confers any advantages.
Materials and methods
After completion of the Wrst 100 cases, to minimize the
eVect of the learning curve [12], 40 consecutive men under-
went RALP by one surgeon (WDS) at our institution. All
patients were referred for elevated PSA and biopsy-proven
prostate cancer.
Robotic assisted laparoscopic radical prostatectomy was
performed in the standard transperitoneal fashion in the
manner described in 2002 by Menon [13, 14] After prostate
removal, the urethrovesical anastomosis is sutured in a run-
ning fashion with 3-0 monocryl. An 18 French silicone
foley catheter is placed prior to the completion of the anas-
tomosis and the balloon inXated with 12 cc of normal
saline. The bladder neck and urethra are approximated over
the catheter prior to the Wnal anastomotic sutures and any
slack in the running suture is removed. The Wrst 20 men had
the running sutured anastomosis without addition of Wbrin
sealant and served as the control group. The second group
of 20 men underwent the running anastomosis in the same
standard fashion with addition of 6 cc Wbrin sealant Tisseel
VH in an omega pattern starting at the right posterior and
moving to the left posterior border. The laparoscopic appli-
cator is passed through the right assistant 12 French port.
(Fig. 1). Both groups of patients had a 15 French round JP
drain placed at the urethrovesical anastomosis, via the
5 mm suction port, at the completion of the case.
Patients were discharged to the post anesthesia care unit
and then to the surgical Xoor where output from the JP
drain was measured for eight-hour intervals. Drains were
removed when output was less than 60 cc per shift after
ambulation. Volume of JP output per shift, date of JP
removal, and date of discharge were recorded for each
patient and obtained from the medical record and bedside
chart. Patients were scheduled for follow up at seven days
with a cystogram. Hundred and Wfty milliliters of dilute
Omnipaque contrast material were instilled under gravity
per catheter under Xuoroscopic guidance. If leak was dem-
onstrated the procedure was repeated a week later. Date of
removal of Foley catheter was recorded as was presence or
absence of anastomotic leak.
Data were collected in a retrospective chart review for
factors that would inXuence tissue healing, including
smoking history, use of steroids, and presence of diabetes.
Presence of ileus, readmission data, and follow up were
also obtained retrospectively. The University of Virginia
Institutional Review Board approved the study.
Prostate specimens were sent to pathology for analysis
upon removal. Prostate size was measured in grams. Final
pathologic staging was determined by the pathologist at the
time of accessioning as was Gleason grade on the prostate
specimen.
Mean, standard deviation, and standard error were calcu-
lated for the data in each group. Wilcoxon rank sum
test was used to determine statistical signiWcance for the
comparison.
Results
The control group and the Tisseel VH group were matched
for age, preoperative PSA, Gleason grade, prostate size,
and pathologic stage at removal. There were no statistically
signiWcant diVerences between the two groups (Table 1).
The Jackson–Pratt drain was removed on mean POD 2.1
(range 1–13 SE 0.632) in the control group and mean POD
1.3 (range 1–3 SE 0.147) in the Tisseel group (P = 0.23).
This was equivalent to a mean of 3.8 nursing shifts (range
2–8 SE 0.484) in the control and a mean of 3.1 nursing
shifts (range 2–8 SE 0.347) in the Tisseel group (P = 0.24).
Patients were discharged on POD 1.4 (range 1–3 SE 0.152)
in the control, and POD 1.3 (range 1–3 SE 0.147) in the
Tisseel group (P = 0.64). For the control group the cc per
shift JP output was 63.24 (range 8–435 SE 20.75). For
the Tisseel group the cc per shift JP output was 38.65
(range 0–100 SE 4.84) (P = 0.26). Catheter removal was
on POD 12.1 (range 7–26 SE 1.397) in the control group. In
the Tisseel group the catheter was removed on POD 9.75
(range 7–18 SE 0.602) (P = 0.13) (Table 2).
One patient in the Tisseel group failed one cystogram
trial, and no patient was readmitted with large-volume leak
or ileus. In the control group, two patients failed one cysto-
gram trial, one patient failed two cystogram trials, and twoFig. 1 Fibrin sealant applied over the urethrovesical anastomosis123
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output and ileus Table 3.
Factors potentially contributing to poor wound healing
and thereby aVecting results were also taken into account
(Table 3). Smoking history, steroid use, and diabetes diag-
nosis were all retrospectively reviewed. In the control
group: one patient had diet-controlled diabetes, no patient
had a history of steroid use, eight patients were former
smokers, and one patient was a current smoker. In the Tis-
seel group: no patient had diabetes, no patient had a history
of steroid use, ten patients were former smokers, and one
patient was a current smoker. No statistically signiWcant
diVerences were noted in these parameters for the two
groups.
Discussion
First introduced for use in cardiothoracic surgery in 1988
[1], the use of Wbrin sealant and other tissue sealant and
hemostatic products has expanded across surgical disci-
plines in the last two decades. In urology, Wbrin sealants are
the most commonly employed, and though many applica-
tions are oV-label uses, there has been mounting evidence
for their usefulness in urology [6–11]. Diner et al. [11]
report that use in radical retropubic prostatectomy decreases
perioperative drain output, and suggest that in some patients
undergoing traditional open radical prostatectomy application
of Wbrin sealant could accelerate discharge. Morey et al.
Table 1 Comparison of control 
and study groups for age, PSA, 
Gleason grade, pathologic stage, 
and prostate size
Control group Tisseel group
Age
Mean 60.55 SE 1.758 58.25 SE 1.285 P = 0.29
Range 48–73 46–66
PSA
Mean 5.23 SE 0.45 4.708 SE 0.64 P = 0.51
Range 3.1–10.2 0.36–11.96
Gleason grade
Mean 6.3 SE 0.128 6.5 SE 0.115 P = 0.251







Mean 51.7 SE 3.208 47.73 SE 3.021 P = 0.37
Range 31–82.6 33.92–85
Table 2 Comparison of control and study groups for drain removal,
date of discharge, date of catheter removal, and cc per shift of drain
output
Control group Tisseel group P value
JP drain removal POD#
Mean 2.1 SE 0.632 1.3 SE 0.147 P = 0.23
Range 1–13 1–3
JP drain # shifts
Mean 3.8 SE 0.484 3.1 SE 0.347 P = 0.24
Range 2–8 2–8
Discharge POD#
Mean 1.4 SE 0.152 1.3 SE 0.147 P = 0.64
Range 1–3 1–3
Catheter removal POD#
Mean 12.1 SE 1.397 9.75 SE 0.602 P = 0.130
Range 7–26 7–18
cc per shift
Mean 63.24 SE 20.75 38.65 SE 4.84 P = 0.26
Range 8–435 0–100
Table 3 Comparison of factors aVecting healing and rate of ileus in
the control and study groups
Control group Tisseel group





Steroid use 0 0
Diabetes 1 (diet controlled) 0123
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and those patients required no perioperative drain [15]. Evans
et al. [8] report success with use of Wbrin sealant in trauma
and Wstula repair. Novel uses of Wbrin sealant in urology
utilize its use as a hemostatic adjunct in partial nephrectomy
and renal trauma, and as a sealant in hypospadias, ureteral
anastomoses, and urethroplasty [6, 8]. Several case reports
and small series exist supporting the use in pyeloplasty,
vasovasostomy, ureteral anastomosis, and open radical pro-
statectomy. In our study we expand the potential use to
include reinforcing the urethrovesical anastomosis in RALRP.
Already shown to reduce drain output in the open radical
prostatectomy [11] and to assist in the two-sutured anasto-
motic technique described by Gallo et al [16], Tisseel’s use in
this realm seems a natural progression given the minimally
invasive nature of the procedure and reduced hospital stay.
In our study, the main outcome diVerence noted was in
leakage prior to catheter removal. We were not able to Wnd
a statistically signiWcant diVerence in JP drain output or
days with JP drain, likely because most patients with JP
drains have them removed after a relatively short interval.
JP was removed in 2.1 versus 1.3 days in the control and
Tisseel groups (P = 0.23). Similarly discharge home was
not statistically diVerent with most patients able to leave on
POD 1. Days in the hospital were 1.4 in the control group
and 1.3 in the Tisseel group. Catheter removal was earlier
in the study group 9.75 versus 12.1 days, with a trend
toward statistical diVerence (P = 0.13) (Table 2).
Where the use of Wbrin sealant was most noticeable was
at follow up cystogram and catheter removal. Once Tisseel
was introduced, only one patient had leak on cystogram and
had to return for a repeat cystogram compared to six in the
control group. No patient was readmitted with leak or ileus
in the study population while two in the control group were
readmitted with ileus. We examined other factors that could
account for poor tissue healing including smoking, steroid
use, and diabetes and found no signiWcant diVerences. We
conclude that application of the Wbrin sealant aids in heal-
ing and sealing the anastomosis and accounts for the
reduced leakage.
Conclusion
Use of Wbrin sealant in urology can be expanded to include
reinforcing the suture line in the urethrovesical anastomosis
in RALRP. Application of Wbrin sealant at the urethrovesical
anastomosis appears to facilitate sealing, thereby allowing
earlier removal of the JP drain by 0.8 days and the Foley
catheter by 2.35 days in patients undergoing RALRP. No
patients in the Wbrin sealant group suVered post-operative
ileus. This adjunct may be especially useful early in the
learning process to reduce morbidity. Further study to vali-
date the procedure should be undertaken and a cost-eVective
approach to use should be employed.
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